TSH BiopharmROCO:8432 +0.79%84 OCF Margin % is 11.28% as of Dec. 2025, which is 0% below its 10-year median of 11.29. GuruFocus rates ROCO:8432 with a GF Score™ of 84/100 and a GF Value™ of NT$78.55 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 959 Drug Manufacturers companies, TSH Biopharm ranks better than 52.24% on this metric.
The historical rank and industry rank for TSH Biopharm's OCF Margin % or its related term are showing as below:
ROCO:8432'
s OCF Margin % Range Over the Past 10 Years
Min: 2.59 Med: 11.29 Max: 17.46
Current: 10.44
During the past 13 years, the highest OCF Margin % of TSH Biopharm was 17.46%. The lowest was 2.59%. And the median was 11.29%.
ROCO:8432's OCF Margin % is ranked better than 52.24% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs ROCO:8432: 10.44
TSH Biopharm OCF Margin % Related Terms
TSH Biopharm OCF Margin % Historical Data
* Premium members only.
The historical data trend for TSH Biopharm's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TSH Biopharm OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's OCF Margin % distribution charts can be found below:
* The bar in red indicates where TSH Biopharm's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSH Biopharm (ROCO:8432) has a OCF Margin % of 11.28% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TSH Biopharm and its competitors. This is near median its historical median of 11.29. Over the past decade, TSH Biopharm's OCF Margin % has ranged from 2.59 to 17.46. According to the industry distribution chart, TSH Biopharm ranks #458 out of 959 companies in the Drug Manufacturers industry, placing it in the top 47.8%.
Is TSH Biopharm's OCF Margin % too high?
TSH Biopharm's current OCF Margin % of 11.28% is near median its 10-year median of 11.29. Over the past 10 years, this metric has ranged from a low of 2.59 to a high of 17.46. The Drug Manufacturers industry median OCF Margin % is 9.95. TSH Biopharm's value of 11.28% is 13.4% above this industry median. Based on the distribution chart, TSH Biopharm ranks #458 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TSH Biopharm has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TSH Biopharm's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TSH Biopharm ranks #458 out of 959 companies for OCF Margin %. This puts TSH Biopharm in the upper half of its industry. The industry median OCF Margin % is 9.95. TSH Biopharm's value of 11.28% is 13.4% above this benchmark. Historically, TSH Biopharm's own OCF Margin % has ranged from 2.59 to 17.46 over the past decade. While the company's 10-year median is 11.29 vs. the industry median of 9.95, TSH Biopharm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TSH Biopharm's current OCF Margin % of 11.28% is 13.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TSH Biopharm and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TSH Biopharm's current OCF Margin % is 11.28%, which is near median its own 10-year median of 11.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TSH Biopharm stock overvalued right now?
Based on GuruFocus' analysis, TSH Biopharm (ROCO:8432) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$78.55, compared to a current price of NT$50.80 — trading 35.3% below its estimated fair value. The current OCF Margin % is 11.28%, which is near median its 10-year median of 11.29 and 13.4% above the Drug Manufacturers industry median of 9.95. TSH Biopharm's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TSH Biopharm (ROCO:8432), the current OCF Margin % is 11.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TSH Biopharm (ROCO:8432) Overvalued in 2026?
Based on GuruFocus' analysis, TSH Biopharm stock appears to be undervalued.
The current stock price of NT$50.80 is trading 35.3% below its estimated GF Value™ of NT$78.55.
GuruFocus considers TSH Biopharm to be Significantly Undervalued.
Key valuation signals for ROCO:8432:
OCF Margin %: 11.28% (near median its 10-year median of 11.29)
GF Value™: NT$78.55 vs. price of NT$50.80 (35.3% below fair value)
Industry Position: 13.4% above the Drug Manufacturers median (#458 of 959)
No single metric tells the full story. See the ROCO:8432 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TSH Biopharm Corp Ltd is engaged in sale of a variety of pharmaceuticals, chemical drugs and engaged in biotechnology services. The company specializes in the development, manufacture, and marketing of branded drugs for chronic diseases. Key therapeutic areas include cardiovascular, central nervous system, gastroenterology, and severe chronic diseases, alongside precision medicine/genetic testing services .The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.
84GF Score
Get the complete analysis for ROCO:8432
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8432 has been successfully added to your 
